Inventiva
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Inventiva and buy or sell other stocks, options, and ETFs commission-free!About IVA
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors.
CEOFrédéric Cren
CEOFrédéric Cren
Employees113
Employees113
HeadquartersDaix, Bourgogne-Franche-Comte
HeadquartersDaix, Bourgogne-Franche-Comte
Founded2011
Founded2011
Employees113
Employees113
IVA Key Statistics
Market cap226.18M
Market cap226.18M
Price-Earnings ratio-2.16
Price-Earnings ratio-2.16
Dividend yield—
Dividend yield—
Average volume61.12K
Average volume61.12K
High today$5.21
High today$5.21
Low today$4.12
Low today$4.12
Open price$4.21
Open price$4.21
Volume191.33K
Volume191.33K
52 Week high$5.21
52 Week high$5.21
52 Week low$2.22
52 Week low$2.22
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%